skip to Main Content

Many Patients with Pancreatic Cancer Miss Out on Treatment that May Extend Survival

Many Patients with Pancreatic Cancer Miss Out on Treatment that May Extend Survival
Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, and even more do not receive cancer-directed treatment, found new research published in CMAJ (Canadian Medical Association Journal). Pancreatic cancer has a high death rate and is often diagnosed in advanced stages.

“The data suggest that there are many missed opportunities for important discussions between patients and cancer specialists,” says Dr. Natalie Coburn, an author of the study and a surgical oncologist at Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario. Read more  . . . 


Back To Top